The Pharmaceutical Journal
Vol 279 No 7469 p283
15 September 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

DTB questions routine self-monitoring of blood glucose

Routine self-monitoring of blood glucose by people with type 2 diabetes who have reasonable glycaemic control offers little advantage and may increase the likelihood of hypoglycaemia, according to the latest issue of the Drug and Therapeutics Bulletin.

The September 2007 DTB says that type 2 diabetes patients who are experiencing hypoglycaemia may benefit from self-monitoring but for those who have little risk of hypoglycaemia, measuring HbA_1c concentration may be more appropriate.